Back to the main directory
EarningsReview / Equity
- Postcard from Karlshamn: feedback from the CMD by BNP Paribas Exane
- Valuation update by DnB Markets
- China Education Group (839 HK) by HSBC
- F4Q ARR comments lead to indigestion by BNP Paribas Exane
- Are we there yet? by BNP Paribas Exane
- Grateful For Uncrustables by BNP Paribas Exane
- Alpha Aces: A Great Reshuffle by BNP Paribas Exane
- (Still) Plenty to play for… by BNP Paribas Exane
- CSRD, CS3D, taxonomie… tout le monde à bord de l’omnibus ? by Oddo BHF
- Comer Industries - EBITDA MARGIN SHOWED TO BE RESILIENT IN A TOUGH MARKET by Equita Sim
- Updated financial targets by BNP Paribas Exane
- H1’25 results First Take - H1 EBIT miss, FY guide retained by BNP Paribas Exane
- CSRD, CS3D, taxonomy...all aboard the omnibus? by Oddo BHF
- NHY, AAL, MT, STEEL CHINA, GREEN STEEL by BNP Paribas Exane
- Teleperformance - American Sign Language by MidCap Partners
- INVEST SECURITIES - MEDESIS : Aucun effet indésirable à 12 mois avec Nanolithium - NEUTRE, OC 3,3€ by Invest Securities
- INVEST SECURITIES - NACON : Hell is Us, le remède pour sortir de l'enfer ? ACHAT, OC 1,8€ (vs 1,9€) by Invest Securities
- INVEST SECURITIES - TME PHARMA : NOX-A12, potential confirmed in combination with ICI - BUY, TP €0,49 by Invest Securities
- H1 24/25 conference call feedback by BNP Paribas Exane
- Pennon conference call key points and views by BNP Paribas Exane
- Luk Fook (590 HK) by HSBC
- 国检集团（603060 CH） by HSBC
- Another clean bill of health from the regulators - this time on loyalty pricing by BNP Paribas Exane
- NA-25%-TA by BNP Paribas Exane
- Demonstrated turnaround by BNP Paribas Exane